Literature DB >> 26709806

Optogenetic user's guide to Opto-GPCRs.

Sonja Kleinlogel1.   

Abstract

Optogenetics has taken biomedical research by storm. The power and precision at which light-gated ion channels control cellular excitability in diverse biological systems has convinced researchers of an optical future. Growing interest in optical methods has sparked the development of multiple new optogenetic tools, which allow precise control of numerous cellular processes. Among these new tools are the light-activatable G-protein coupled receptors (GPCRs) or Opto-GPCRs. The extent of the GPCR family, which in humans alone encompasses approximately 800 different proteins, and the immense therapeutic potential of Opto-GPCRs predict a big future for this juvenile field. Here the different approaches taken to design Opto-GPCRs are reviewed, outlining the advantages and disadvantages of each method for physiological and potential clinical application.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26709806     DOI: 10.2741/4421

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  12 in total

Review 1.  Molecular tools for acute spatiotemporal manipulation of signal transduction.

Authors:  Brian Ross; Sohum Mehta; Jin Zhang
Journal:  Curr Opin Chem Biol       Date:  2016-09-14       Impact factor: 8.822

2.  Light-Sensitive Membrane Proteins as Tools to Generate Precision Treatments.

Authors:  Elena Lesca
Journal:  J Membr Biol       Date:  2020-04-04       Impact factor: 1.843

Review 3.  Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits.

Authors:  Skylar M Spangler; Michael R Bruchas
Journal:  Curr Opin Pharmacol       Date:  2016-11-19       Impact factor: 5.547

4.  Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina.

Authors:  Jakub Kralik; Michiel van Wyk; Nino Stocker; Sonja Kleinlogel
Journal:  Commun Biol       Date:  2022-10-20

5.  A photoswitchable GPCR-based opsin for presynaptic inhibition.

Authors:  Bryan A Copits; Raaj Gowrishankar; Patrick R O'Neill; Jun-Nan Li; Kasey S Girven; Judy J Yoo; Xenia Meshik; Kyle E Parker; Skylar M Spangler; Abigail J Elerding; Bobbie J Brown; Sofia E Shirley; Kelly K L Ma; Alexis M Vasquez; M Christine Stander; Vani Kalyanaraman; Sherri K Vogt; Vijay K Samineni; Tommaso Patriarchi; Lin Tian; N Gautam; Roger K Sunahara; Robert W Gereau; Michael R Bruchas
Journal:  Neuron       Date:  2021-05-11       Impact factor: 18.688

6.  Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad.

Authors:  Michael Perny; Lukas Muri; Heather Dawson; Sonja Kleinlogel
Journal:  Cell Death Dis       Date:  2016-11-03       Impact factor: 8.469

Review 7.  And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation.

Authors:  Jean Delbeke; Luis Hoffman; Katrien Mols; Dries Braeken; Dimiter Prodanov
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

Review 8.  Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells.

Authors:  Jordan E Pomeroy; Hung X Nguyen; Brenton D Hoffman; Nenad Bursac
Journal:  Theranostics       Date:  2017-08-18       Impact factor: 11.556

Review 9.  The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.

Authors:  Ting-Yun Chen; Xiaoyun Li; Ching-Hsia Hung; Harinath Bahudhanapati; Jiangning Tan; Daniel J Kass; Yingze Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-02-26       Impact factor: 2.183

Review 10.  Silencing Neurons: Tools, Applications, and Experimental Constraints.

Authors:  J Simon Wiegert; Mathias Mahn; Matthias Prigge; Yoav Printz; Ofer Yizhar
Journal:  Neuron       Date:  2017-08-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.